This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1126/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q51026520
rdf:type
wikibase:Item
schema:description
scienca artikolo artículu científicu artikel ilmiah artykuł naukowy bài báo khoa học wissenschaftlicher Artikel научная статья 2013年学术文章 artigo científico مقالة علمية نشرت في مايو 2013 2013年学术文章 научни чланак artikull shkencor 2013年学术文章 videnskabelig artikel 2013년 논문 2013年學術文章 bilimsel makale 2013年學術文章 2013 nî lūn-bûn vetenskaplig artikel article científic 2013年の論文 мақолаи илмӣ scientific article published in May 2013 vedecký článok article scientific articolo scientifico επιστημονικό άρθρο tieteellinen artikkeli 2013年学术文章 artigo científico wetenschappelijk artikel наукова стаття, опублікована в травні 2013 vitskapeleg artikkel tudományos cikk 2013年學術文章 artículo científico publicado en 2013 artikulong pang-agham 2013年学术文章 teaduslik artikkel article scientifique სამეცნიერო სტატია научна статия scientific article published in May 2013 מאמר מדעי naučni članak 2013年学术文章 artigo científico vitenskapelig artikkel научни чланак 2013年學術文章 মে ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2013年學術文章 articol științific scientific article published in May 2013 บทความทางวิทยาศาสตร์ vědecký článek
p:P577
wds:Q51026520-FD37E171-5640-419A-83BE-9A5B4F896E44
wdt:P577
2013-05-01T00:00:00Z
p:P407
wds:Q51026520-A2BA22CE-A7BD-42F7-8D30-50317EA2F58D
wdt:P407
wd:Q1860
p:P2093
wds:Q51026520-11A0470E-6258-4B53-8459-568929B73EAF wds:Q51026520-1BD5342C-12FC-4654-8B40-C9A74EB756C1 wds:Q51026520-008DA2E3-95D7-4F99-9750-54ED2658E3DE wds:Q51026520-0A05380D-9E68-49FA-B14A-ED5E4BA1B39B wds:Q51026520-BCB513AE-6068-4234-AD6F-C7D72C1EA787 wds:Q51026520-BDA35B45-1A78-4063-BE37-52C38E0F40E0 wds:Q51026520-9DC7A889-45C6-4CBB-83DF-4F42D2F3F5B4 wds:Q51026520-A04CE49E-454C-4772-8733-46AC87D941EB wds:Q51026520-8ACAC32C-DA60-4392-9B71-95BD08C4EC55 wds:Q51026520-D4B506F0-E2F2-4401-9C59-5927F9F0C18D wds:Q51026520-DB0E136E-EAC0-481F-952F-1376D2ADAA3D wds:Q51026520-52DE2912-2361-44B0-B969-B37FD6E0DCB1 wds:Q51026520-53E06292-5930-4D17-A5FC-6EEB8CE67548 wds:Q51026520-26E4F44F-CFFC-45DD-93FE-0F30187E4143 wds:Q51026520-1EDB19F6-CC0B-4D8C-8737-2B168F62A426 wds:Q51026520-782DBC53-CF5E-4FFB-B93D-26CF3F5510C2 wds:Q51026520-823B09D4-7FD5-429E-947E-A65B84E714AA wds:Q51026520-68516FC8-13B3-4500-8784-74FFFE08D463 wds:Q51026520-7153BBEF-ED61-45F1-924C-FF12CE8D32E2 wds:Q51026520-5F91F373-D4D2-49A6-85F6-B0CCA92A4768 wds:Q51026520-62867D2D-1804-4F59-870C-4DE3A3150F46 wds:Q51026520-53EAAE2F-9FD0-4468-AB44-2C35551AC793
wdt:P2093
James A Ernst Yin Zhang Kapil Gadkar Wilman Luk Raymond K Tong Jacqueline M Tarrant William J Meilandt Quyen Nguyen Kimberly Scearce-Levie Y Joy Yu Jessica A Couch Reina N Fuji Yuwen Lin Saileta Prabhu Mercedesz Balazs Benjamin A Ordonia Ryan J Watts Hilda Solanoy Zhonghua Lin Yanmei Lu Kwame Hoyte Mark S Dennis
rdfs:label
Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier. Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier.
skos:prefLabel
Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier. Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier.
schema:name
Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier. Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier.
p:P1476
wds:Q51026520-24C499CD-311E-4B6C-A8C0-E0566FB00D6B
wdt:P1476
Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier.
p:P304
wds:Q51026520-4AFADF3C-4928-467D-A9B3-FF214E171257
wdt:P304
183ra57, 1-12
p:P31
wds:Q51026520-477AA79E-0AAA-4181-896A-A0A7BC5234E5
wdt:P31
wd:Q13442814
p:P921
wds:Q51026520-BFAEEB4A-9FC1-43C3-9DC0-70CF56A6AEAE wds:Q51026520-FCB01408-C84B-4220-BDE0-7226F2FECF46
wdt:P921
wd:Q79460 wd:Q221694
p:P698
wds:Q51026520-F0C29D02-8A6D-4BE3-A9FD-4BD1D7FE4874
wdtn:P698
n12:23636093
wdt:P698
23636093
p:P1433
wds:Q51026520-1D06EBB8-C682-4C8E-A6D2-59E528145E89
wdt:P1433
wd:Q1573955
p:P433
wds:Q51026520-54BC7305-BF72-45A9-8575-05F54695212C
p:P478
wds:Q51026520-949DD546-92FA-4094-83CC-2AA503F7316C
wdt:P433
183
wdt:P478
5
p:P356
wds:Q51026520-ABBE92BF-A869-4984-BFD6-ACB4C84B4C3E
wdtn:P356
n8:SCITRANSLMED.3005338
wdt:P356
10.1126/SCITRANSLMED.3005338
p:P5875
wds:Q51026520-C7ED20C9-3A92-4469-A761-783025ED89E8
wdt:P5875
236602574